Clin2
NCT06313944Possibly a fitRecruiting

German registry of Alzheimer's treated with sound wave therapy

Alzheimer Disease

Part of Brain & nervous system, Mental health clinical trials.

This trial is a registry that collects information about people with Alzheimer's disease who receive a treatment called transcranial pulse stimulation (TPS), which uses gentle sound waves to stimulate the brain. The goal is to track safety and how well it works over time.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years to 85 years
Study type
Observational

Who can take part

  • You are between 18 and 85 years old.
  • You have Alzheimer's disease with gradual memory loss and difficulty with daily tasks for at least 6 months.
  • You have had an MRI, and if possible, a spinal tap or PET scan showing signs of Alzheimer's.
  • You do not have other serious brain conditions (like tumors, bleeding, or major stroke damage).
  • You do not have a bleeding disorder or take blood thinners.
  • You can receive the treatment at a specialist's office.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06730438Recruiting
Sound wave brain treatment for early dementia

This study tests whether a treatment called Transcranial Pulse Stimulation (using targeted sound waves) can help people with early-stage dementia. It aims to find a new way to improve brain function without surgery or drugs.

L’Aquila, Italy
NCT06597942Recruiting· Phase 1/Phase 2
Deep TMS for Alzheimer's disease

This trial tests a non-invasive brain stimulation technique called deep repetitive TMS on a brain region linked to memory. It aims to see if this treatment can improve symptoms in people with mild-to-moderate Alzheimer's disease.

Los Angeles, California
NCT06817902Enrolling by invitation
TMS for Early Alzheimer's Disease Pilot

This trial tests whether transcranial magnetic stimulation (TMS), a noninvasive brain treatment, can help people with early Alzheimer's or mild cognitive impairment. It aims to see if the treatment is safe and effective for slowing memory decline.

Saint Paul, Minnesota
NCT07075770Recruiting
New magnetic and electrical brain stimulation for mild Alzheimer's

This trial tests a new, noninvasive treatment that combines magnetic and electrical stimulation to target a specific brain network in people with mild Alzheimer's disease. It aims to slow memory decline and improve brain function.

Rome, Italy
NCT06538311Recruiting· Early Phase 1
TMS treatment for early Alzheimer's disease

This study tests whether a non-invasive brain stimulation treatment called TMS (transcranial magnetic stimulation) can help people with early Alzheimer's disease or related memory problems. It's a safe, gentle way to stimulate brain cells using magnetic pulses.

Boston, Massachusetts
NCT06669182Recruiting
Cerebellar TMS for Alzheimer's Disease

This trial uses a non-invasive brain stimulation technique (TMS) to target the cerebellum in people with Alzheimer's disease. It aims to see if this treatment can improve symptoms and cognitive function.

Xi'an, Shaanxi

Hear when a new Alzheimer Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.